Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Questions?
If you have questions or would like to directly discuss your options with AQUA, connect with one of our Registry Coordinators.
Contact Us
AUA Quality (AQUA) Registry
Developed by urologists for urologists, the AUA Quality (AQUA) Registry is a national Qualified Clinical Data Registry (QCDR) designed to measure, report and improve healthcare quality and patient outcomes.
The AQUA Registry collects real-world data directly from your electronic health record (EHR) system to help urologists improve patient diagnosis and treatment outcomes.
The registry’s automated system and intelligent design allow urology practices to participate in quality improvement activities, contribute to national urology benchmarks, and access quality measures meaningful to urologists.
AQUA now offers a Standard Subscription option, allowing accessible participation in the leading urology data registry with no fees from the AUA. Learn more about our new pricing options.
AQUA in Action
The AUA is proud to feature the latest in Urology with AQUA in Action. These articles will include the latest articles from AUANews and select articles from Verana Health.
- The Journal of Urology®: Active Surveillance for Low-risk Prostate Cancer: Time Trends and Variation in the AUA Quality (AQUA) Registry (To appear)
- The Journal of Urology®: Insights from the AUA Quality (AQUA) Registry: A Retrospective Study of Anticholinergic Polypharmacy in the United States, Therapeutic Advances in Urology (To appear)
- The Journal of Urology®: Patterns of Surgical Management of Male Stress Urinary Incontinence: Data from the AUA Quality (AQUA) Registry
- AUANews: Regional and Time Trends in Post-Prostatectomy Interventions
- AUANews: Baseline Bone Density Evaluation among Men on Androgen Deprivation Therapy
- AUANews: Trends in Utilization of Office-Based Urethral Dilation for Women: An AQUA Registry Analysis
- The Journal of Urology®: Impact of the COVID-19 Pandemic on Urological Care Delivery in the United States
- Urology Practice®: Characteristics of Participants in the American Urological Association Quality (AQUA) Registry and Early Impact of Participation on Quality of Care
- Urology: Significant Management Variability of Urethral Stricture Disease in United States: Data from the AUA Quality (AQUA) Registry
Important News
The AUA is pleased to announce it has entered into a collaboration with Verana Health, a healthcare technology firm focused on curating and analyzing health care data to advance medical research and innovative medical care for patients.
This alliance, along with our existing collaboration with FIGmd, will allow us to build new analytical applications and user interfaces to advance the science of urology, fuel research discoveries, and ultimately improve the lives of patients.
Read FAQs.
Dates to Remember
April 1, 2024 –December 2, 2024
- 2024 MVP registration window.
- To register, sign into the QPP website with your HCQIS Access and Roles Profile (HARP) account. **A HARP account is required to complete registration.**
August 30, 2024
- Existing practices to provide measure feedback for refinements and make final measure changes for any “not feasible” measures.
September 30, 2024
- Finalize your 2024 provider list and location information through the "My Account" section of the AQUA Registry Dashboard.
October 3, 2024
- Last day to start a 90-day performance period for Improvement Activities.
October 31, 2024
- Data Release Consent Forms (DRCF) are available via the AQUA Registry dashboard.
- Last day to submit measure refinements for 2024 selected measures.
*Submissions are not allowed at this point.
advertisement
advertisement